5382 篇
13903 篇
477846 篇
16282 篇
11762 篇
3926 篇
6535 篇
1251 篇
75602 篇
37765 篇
12159 篇
1658 篇
2861 篇
3418 篇
641 篇
1240 篇
1973 篇
4916 篇
3874 篇
5476 篇
秘鲁制药和医疗保健行业报告(2019-2020年)
Peru Pharma and Healthcare Sector Report 2019-2020
The level of competition in Peru’s pharma and healthcare sector varies across segments. Pharmaceutical retail exhibits a low degree of competition, with one Peruvian company – InRetail Peru – operating five pharmaceutical chains (i.e. Inkafarma, Vanttive, BTL, FASA and MiFarma), which accounted for 58% of drug sales in value terms in 2017. Health insurance is largely controlled by the government, which runs both the public health insurance scheme (SIS) and the social security health insurance scheme (EsSalud). However, the still small private health insurance market has recently grown in size and number of players, registering a moderate degree of competition.
01 EXECUTIVE SUMMARY
02 SECTOR IN FOCUS
03 COMPETITIVE LANDSCAPE
04 COMPANIES IN FOCUS
05 REGULATORY ENVIRONMENT
06 PHARMACEUTICALS
07 HEALTHCARE
08 RETAIL CHANNELS